News section

home  |  news  |  forum  |  job market  |  calendar  |  yellow pages  |  advertise on SeedQuest  |  contact us 

 

Syngenta chairman takes temporary leave of absence to receive medical treatment
Basel, Switzerland
May 20, 2005

Syngenta announces that its Chairman, Heinz Imhof, is currently receiving medical treatment and has taken temporary leave of absence from the company. During his absence, the Vice-Chairman, Martin Taylor, will assume the role of acting Chairman.

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innova-tive research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2004 were approximately $7.3 billion. Syngenta employs some 19,000 people in over 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT).


Syngenta gibt bekannt, dass der Präsident des Verwaltungsrates, Heinz Imhof, sich zur Zeit in medizinischer Behandlung befindet und daher vorübergehend seine Tätigkeit nicht ausüben kann. Während seiner Abwesenheit wird der Vize-Präsident des Verwaltungsrates, Martin Taylor, stellvertretend seine Aufgaben übernehmen.


Syngenta annonce que son président du Conseil d’Administration M. Heinz Imhof est actuellement sous traitement médical et se trouve en congé maladie. Pendant son absence, c'est M. Martin Taylor, vice-président du Conseil d’Administration, qui assumera les responsabilités du président par intérim.

News release

Other news from this source

12,316

Back to main news page

The news release or news item on this page is copyright © 2005 by the organization where it originated.
The content of the SeedQuest website is copyright © 1992-2005 by SeedQuest - All rights reserved
Fair Use Notice